ScholarIQanswers from OpenAlex

Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics

PaperCitations, authors & open-access status

Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics have?

ScholarIQcitation count

Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics has 37 citations in the OpenAlex counts ScholarIQ stores.

When was Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics published?

ScholarIQyear

Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics has 2022 year in the ScholarIQ index.

What is the open-access status of Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics?

ScholarIQoa status

Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics has bronze oa status in the ScholarIQ index.

What is the DOI of Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics?

ScholarIQdoi

The DOI for Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics is on the source record.

What is the PMID of Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics?

ScholarIQpmid

The PMID for Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics is on the source record.

What is the OpenAlex record for Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics?

ScholarIQopenalex

The OpenAlex for Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial